Actively Recruiting
Evaluation of Fibroblast Activating Protein FAP PETCT Imaging in Adults with Pulmonary Tuberculosis to Assess Lung Fibrosis and Damage
Led by University of Pennsylvania · Updated on 2026-09-21
10
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting an early phase study in adults with pulmonary Tuberculosis TB to evaluate Fibroblast Activating Protein FAP activation as a marker of lung fibrosis. The study aims to use FAP PETCT imaging to identify the extent and location of FAP signals in the lungs of TB patients both early in treatment and after cure. This is intended to help develop treatments that could prevent, predict, or treat Post-transplant Lymphoproliferative Disorder PTLD, with the hypothesis that higher FAP signals are linked to greater lung damage after TB cure. Participants will receive an intravenous injection of approximately 6 to 8 mCi of 18F-FAPI-74, followed by PETCT scans from the head to mid-thigh about 30 minutes after injection. High-resolution CT HRCT scans of the chest will also be performed at baseline and after TB cure, either on the same day or different days. The study will enroll up to 10 participants over about 2 years, with imaging done within 6 weeks of treatment start and again within 6 months after cure to assess changes in FAP signals and lung damage. During the study, participants will undergo PETCT and HRCT imaging sessions, and data will be collected to evaluate FAP uptake and lung structural changes. The primary outcome is to determine the relationship between changes in lung FAP PET signals and lung damage over 6 months of TB treatment. Secondary outcomes include assessing associations between early FAP signals and persistent lung damage after cure. The study is observational with no masking and follows participants up to the study completion date in 2030.
CONDITIONS
Brief Title
Fibroblast Activating Protein (FAP) PET/CT in Adults With Tuberculosis
Research Team
M
Mark A Sellmyer, MD
E
Erin Schubert
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here